Sabitlenmiş Tweet

Major Announcement for the MindWaveDAO Community
Apimeds Pharmaceuticals US Inc, (NYSE American: APUS), has officially merged with MindWave Innovations Inc., bringing together late-stage biotech development and AI-driven digital-treasury intelligence under one unified entity.
Apimeds adds significant strength on the biotech side, including its advanced non-opioid pain-management pipeline and the biologic candidate Apitox. This expands the combined company’s long-term growth potential in the healthcare and wellness sectors.
MindWave contributes its institutional-grade Bitcoin-treasury infrastructure, AI-based yield generation systems, and a growing ecosystem powered by the NILA token. This merger strengthens the foundation for long-term treasury performance and DAO-led innovation.
The transaction is supported by a $100 million PIPE, giving the combined entity strong capital backing to accelerate both biotech development and digital-asset infrastructure expansion.
This marks an important step in building a diversified, globally scalable MindWave ecosystem that connects biotech growth with decentralized financial intelligence.
Full announcement:
markets.ft.com/data/announce/…
#MindWaveDAO #NILAToken #AQUAE #DeFi #SDGs #MindWaveInnovationsInc

English








